Cite
HARVARD Citation
Lewis, M. et al. (2021). V3-Loop genotypes do not predict maraviroc susceptibility of CCR5-tropic virus or clinical response through week 48 in HIV-1–infected, treatment-experienced persons receiving optimized background regimens. Antiviral chemistry & chemotherapy. p. . [Online].